These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35954323)

  • 1. Identification of Prognostic Genes in Gliomas Based on Increased Microenvironment Stiffness.
    Chen CR; Chang RS; Chen CS
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients.
    Zhong Q; Zhong Q; Cai X; Wu R
    Genes Genomics; 2023 Sep; 45(9):1211-1226. PubMed ID: 37301776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
    Tan S; Spear R; Zhao J; Sun X; Wang P
    Front Genet; 2022; 13():905047. PubMed ID: 35832194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas.
    Peng P; Chen ZR; Zhang XL; Guo DS; Zhang B; He XM; Wan F
    Curr Med Sci; 2023 Feb; 43(1):156-165. PubMed ID: 36867360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.
    Wang LJ; Lv P; Lou Y
    Front Oncol; 2022; 12():862723. PubMed ID: 35574375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
    Wei B; Wang L; Zhao J
    Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
    Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
    J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.
    Wang Z; Liu X; Wang Z; Bao Z; Zhang W; Zhang C; Jiang T
    Curr Mol Med; 2018 Mar; 17(7):518-526. PubMed ID: 29437008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
    Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
    PeerJ; 2021; 9():e11422. PubMed ID: 34040895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
    Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
    Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma.
    Zhang D; Wang W; Zhou H; Su L; Han X; Zhang X; Han W; Wang Y; Xue X
    Front Genet; 2022; 13():851505. PubMed ID: 35711921
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study.
    Liu J; Zhang H; Zhang J; Bing Z; Wang Y; Li Q; Yang K
    PeerJ; 2021; 9():e11350. PubMed ID: 34026352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
    Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
    Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
    Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
    Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 18. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDOST Correlated with Malignancies and Immune Microenvironment in Gliomas.
    Chang X; Pan J; Zhao R; Yan T; Wang X; Guo C; Yang Y; Wang G
    Front Immunol; 2022; 13():917014. PubMed ID: 35812432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.